Back
TG Therapeutics Stock Predictions

Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
49
TGTX
TG Therapeutics
Last Price:
$35.60
Seasonality Move:
-11.38%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaTG Therapeutics Stock Forecast
-
Over the next 52 weeks, TG Therapeutics has on average historically risen by 21% based on the past 28 years of stock performance.
-
TG Therapeutics has risen higher in 12 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
-
Is TG Therapeutics Stock Undervalued?The current TG Therapeutics [TGTX] share price is $35.17. The Score for TGTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
TGTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will TG Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, TG Therapeutics has on average historically risen by 21% based on the past 28 years of stock performance.
TG Therapeutics Stock Rating
Sell
49
TG Therapeutics (TGTX)
is a Sell
Is TG Therapeutics overpriced?
-
TG Therapeutics has risen higher in 12 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
TG Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tgtherapeutics.com
52-Week Data
52-Week High:
46.48
52-Week Low:
16.39
Prediction Charts
Market Cap:
5.6B
Price in USD:
35.17
Volume:
1.7M
Beta:
0.92
Technical Analysis
SMA50:
37.18
SMA100:
36.21
SMA200:
31.89
52-Wk Change:
109.69%
Stock Predictions
-
Is TG Therapeutics stock public?Yes, TG Therapeutics is a publicly traded company.
-
What is the TG Therapeutics stock quote today?The TG Therapeutics stock price is 35.17 USD today.
-
How to buy TG Therapeutics stock online?You can buy TG Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-30 | 35.56 | 35.08 | 35.60 | 34.41 |
Jun-2 | 35.05 | 35.75 | 35.99 | 34.32 |
Jun-3 | 35.50 | 36.41 | 37.05 | 35.30 |
Jun-4 | 37.00 | 37.04 | 37.23 | 36.18 |
Jun-5 | 37.01 | 39.30 | 40.09 | 36.33 |
Jun-6 | 39.81 | 40.06 | 40.54 | 39.41 |
Jun-9 | 40.61 | 39.84 | 40.99 | 39.39 |
Jun-10 | 39.81 | 39.43 | 40.40 | 39.14 |
Jun-11 | 39.45 | 38.32 | 39.75 | 38.11 |
Jun-12 | 37.68 | 37.37 | 38.88 | 37.11 |
Jun-13 | 36.55 | 36.01 | 37.19 | 35.88 |
Jun-16 | 36.48 | 35.63 | 36.75 | 35.43 |
Jun-17 | 35.06 | 35.00 | 35.52 | 34.55 |
Jun-18 | 35.52 | 35.17 | 35.71 | 34.03 |
TG Therapeutics Earnings
TG Therapeutics Earnings Report: Per Share TG Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
TG Therapeutics Forecast Revenue Growth
TG Therapeutics Stock Analysis: Historical quarterly revenues per share for TG Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.18 per share, an increase this year of $0.77 per share, and an increase next year of $0.85 per share.
* TG Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.